Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.

Aliyu ZY, Suleiman A, Attah E, Mamman AI, Babadoko A, Nouraie M, Mendelsohn L, Kato GJ, Gordeuk VR, Gladwin MT.

Br J Haematol. 2010 Jul;150(1):102-7. doi: 10.1111/j.1365-2141.2010.08195.x. Epub 2010 Apr 16.

2.
3.

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730.

PMID:
18381543
4.

Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.

Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, Godeau B, Galacteros F, Brun-Buisson C, Brochard L, Maitre B.

Am J Respir Crit Care Med. 2008 Mar 15;177(6):646-53. doi: 10.1164/rccm.200710-1606OC. Epub 2008 Jan 3.

PMID:
18174543
5.

Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the Heart and Soul Study.

Desai AS, Bibbins-Domingo K, Shlipak MG, Wu AH, Ali S, Whooley MA.

Eur J Heart Fail. 2007 Sep;9(9):886-91. Epub 2007 Jul 12.

6.

Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E.

Haematologica. 2007 Jun;92(6):738-43.

7.

Tissue Doppler imaging a new prognosticator for cardiovascular diseases.

Yu CM, Sanderson JE, Marwick TH, Oh JK.

J Am Coll Cardiol. 2007 May 15;49(19):1903-14. Epub 2007 Apr 30. Review.

8.

NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients.

Kremastinos DT, Tsiapras DP, Kostopoulou AG, Hamodraka ES, Chaidaroglou AS, Kapsali ED.

Eur J Heart Fail. 2007 May;9(5):531-6. Epub 2007 Feb 21.

9.

Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Sachdev V, Machado RF, Shizukuda Y, Rao YN, Sidenko S, Ernst I, St Peter M, Coles WA, Rosing DR, Blackwelder WC, Castro O, Kato GJ, Gladwin MT.

J Am Coll Cardiol. 2007 Jan 30;49(4):472-9. Epub 2007 Jan 16.

10.

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, Ballas SK, Blackwelder W, Xu X, Hunter L, Barton B, Waclawiw M, Castro O, Gladwin MT; MSH Investigators.

JAMA. 2006 Jul 19;296(3):310-8.

PMID:
16849664
11.

NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension.

Souza R, Jardim C, Julio Cesar Fernandes C, Silveira Lapa M, Rabelo R, Humbert M.

Respir Med. 2007 Jan;101(1):69-75. Epub 2006 Jun 14.

12.
13.

A clinician's guide to tissue Doppler imaging.

Ho CY, Solomon SD.

Circulation. 2006 Mar 14;113(10):e396-8. Review. No abstract available.

14.

Pulmonary hypertension in sickle cell disease.

Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S, Strayhorn D, Lail A, Lieff S, Orringer EP.

Am J Med. 2004 Nov 1;117(9):665-9.

PMID:
15501204
15.

Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea.

Alibay Y, Beauchet A, El Mahmoud R, Brun-Ney D, Alexandre JA, Benoit MO, Dubourg O, Aegerter P, Boileau C, Jondeau G, Puy H.

Clin Biochem. 2004 Oct;37(10):933-6.

PMID:
15369727
16.

Anemia in chronic heart failure: pathogenetic mechanisms.

Okonko DO, Anker SD.

J Card Fail. 2004 Feb;10(1 Suppl):S5-9. Review.

PMID:
15007793
17.

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C, Vogeser M, Kolbe T, Schwaiblmair M, Behr J.

J Am Coll Cardiol. 2004 Mar 3;43(5):764-70.

18.

N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

Kirk V, Bay M, Parner J, Krogsgaard K, Herzog TM, Boesgaard S, Hassager C, Nielsen OW, Aldershvile J, Nielsen H.

Eur J Heart Fail. 2004 Mar 15;6(3):335-41.

19.

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP.

N Engl J Med. 2004 Feb 26;350(9):886-95.

20.

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS.

N Engl J Med. 2004 Feb 12;350(7):655-63.

Supplemental Content

Support Center